+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Effervescent Tablet Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 160 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895159
The global effervescent tablet market size was valued at USD 21.2 billion in 2023, driven by the increasing prevalence of chronic diseases across the globe across the globe. The market size is anticipated to grow at a CAGR of 8.2% during the forecast period of 2024-2032 to achieve a value of USD 43.1 billion by 2032.

Effervescent Tablet: Introduction

Effervescent tablets are pharmaceutical or dietary supplement tablets containing active ingredients like vitamins or pain relievers that, when dissolved in water, produce a fizzy, effervescent solution. They often contain a combination of acids (such as citric acid) and carbonates (like sodium bicarbonate), leading to the release of carbon dioxide. This effervescence enhances drug absorption and can improve taste, making these tablets a popular and palatable option for those who have difficulty swallowing traditional pills.

Key Trends in the Global Effervescent Tablet Market

The global market for effervescent tablets has witnessed dynamic trends in the recent years, reflecting evolving consumer preferences and a heightened focus on health and wellness. Consumers are increasingly drawn to the convenience of effervescent tablets, appreciating their ease of use and pleasant taste compared to traditional dosage forms. A surge in health consciousness has driven the demand for effervescent tablets enriched with vitamins, minerals, and nutritional supplements.

The industry has responded with continuous innovation, exploring novel formulations that incorporate functional ingredients and diverse flavors. Pharmaceutical and nutraceutical companies are expanding their product portfolios, offering a broad spectrum of effervescent formulations tailored to different health needs. The e-commerce boom has facilitated broader consumer access, allowing online platforms to become key distribution channels for effervescent tablets.

The concept of personalized nutrition has permeated the market, leading to the development of effervescent tablets customized to meet specific health requirements and demographics. Sustainability has become a pivotal consideration, prompting initiatives to adopt eco-friendly practices and packaging solutions. The COVID-19 pandemic has intensified the demand for effervescent tablets, particularly those containing immune-boosting ingredients like vitamin C and zinc.

Global Effervescent Tablet Market Segmentation

Market Breakup by Product

  • Medication
  • Supplement

Market Breakup by Type

  • Prescription Based
  • Over The Counter (OTC)

Market Breakup by Application

  • Pharmaceutical
  • Dietary Supplements
  • Dental Products
  • Others

Market Breakup by End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Market Breakup by Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Effervescent Tablet Market Overview

North America has dominated the global effervescent tablets market share due to heightened consumer demand for convenient and palatable dosage forms. The region's leadership is propelled by a surge in health and wellness awareness, a preference for personalized nutrition, and continuous innovation in formulations. Effervescent tablets, enriched with vitamins and minerals, align with consumer preferences for easy-to-use and enjoyable supplements. Robust distribution channels, including extensive e-commerce platforms, further contribute to North America's leading position in the global effervescent tablets market.

The Asia-Pacific region is anticipated to observe substantial growth rapidly, driven by increasing consumer awareness of health and wellness, a rising trend toward convenient dosage forms, and a growing middle-class population. The region's market expansion is further fueled by the introduction of diverse formulations, including personalized and functional ingredients. Additionally, the burgeoning e-commerce landscape enhances product accessibility, contributing to the expected surge in demand for effervescent tablets in the Asia-Pacific market.

Global Effervescent Tablet Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in the market are as follows:

  • Pfizer Inc.
  • GSK plc
  • Novartis AG
  • Bayer AG
  • Perrigo Company plc
  • Reckitt Benckiser Group PLC
  • Bristol-Myers Squibb Company
  • CHIESI SAS
  • Hermes Pharma
  • S. G. Biopharm Pvt. Ltd
  • Bliss GVS Pharma Limited
  • Amerilab Technologies Inc.
  • HERMES ARZNEIMITTEL
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Effervescent Tablet Market Overview
3.1 Global Effervescent Tablet Market Historical Value (2017-2023)
3.2 Global Effervescent Tablet Market Forecast Value (2024-2032)
4 Global Effervescent Tablet Market Landscape
4.1 Global Effervescent Tablet Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Effervescent Tablet Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Type
4.2.3 Analysis by Application
5 Global Effervescent Tablet Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Effervescent Tablet Market Segmentation
6.1 Global Effervescent Tablet Market by Product
6.1.1 Market Overview
6.1.2 Medication
6.1.3 Supplement
6.2 Global Effervescent Tablet Market by Type
6.2.1 Market Overview
6.2.2 Prescription Based
6.2.3 Over The Counter (OTC)
6.3 Global Effervescent Tablet Market by Application
6.3.1 Market Overview
6.3.2 Pharmaceutical
6.3.3 Dietary Supplements
6.3.4 Dental Products
6.3.5 Others
6.4 Global Effervescent Tablet Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Homecare
6.4.4 Specialty Clinics
6.4.5 Others
6.5 Global Effervescent Tablet Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Hospital Pharmacy
6.5.3 Online Pharmacy
6.5.4 Retail Pharmacy
6.5.5 Others
6.6 Global Effervescent Tablet Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Effervescent Tablet Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Effervescent Tablet Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Effervescent Tablet Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Effervescent Tablet Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Effervescent Tablet Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Pfizer Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 GSK plc
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Novartis AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Bayer AG
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Perrigo Company plc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Reckitt Benckiser Group PLC
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Bristol-Myers Squibb Company
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 CHIESI SAS
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Hermes Pharma
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 S. G. Biopharm Pvt. Ltd
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Bliss GVS Pharma Limited
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Amerilab Technologies Inc.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 HERMES ARZNEIMITTEL
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Effervescent Tablet Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket

Companies Mentioned

  • Pfizer Inc.
  • GSK plc
  • Novartis AG
  • Bayer AG
  • Perrigo Company plc
  • Reckitt Benckiser Group PLC
  • Bristol-Myers Squibb Company
  • CHIESI SAS
  • Hermes Pharma
  • S. G. Biopharm Pvt. Ltd
  • Bliss GVS Pharma Limited
  • Amerilab Technologies Inc.
  • HERMES ARZNEIMITTEL

Methodology

Loading
LOADING...